Archives

by in
Entry Author Date Location
MiRagen Therapeutics Raises $7M, Extends Deal with France’s Servier 06/26/14 Boulder/Denver
BIO 2014: Why San Diego is a Hub for RNA R&D and Drug Development 06/23/14 San Diego
RNA Therapeutics Are Here to Stay 06/05/14 San Diego
New Funding, Commercialization Officer at Texas Cancer Agency 05/22/14 Texas
San Diego Life Sciences Roundup: Regulus, Ocera, Lithera, and More 07/18/13 San Diego
With $1.3M in Seed Funding, Arcturus Adds to RNAi Hub in San Diego 06/03/13 San Diego
RNA Therapeutics Are Coming of Age 02/08/13 San Diego
San Diego’s Regulus Lowers Share Price in Revised IPO Filing 10/04/12 San Diego
Regulus Therapeutics Files for IPO as ‘Emerging Growth’ Company 08/20/12 San Diego
Biogen Idec, Regulus Cut Deal to Monitor Multiple Sclerosis 08/15/12 San Diego
The Hepatitis C Market: Biotech’s Version of the Daytona 500 12/12/11 National
Groove Biopharma Snags $6M to Push the Frontiers With MicroRNA Drugs 12/12/11 Seattle
The Fall of Pfizer: How Big is Too Big for Pharma Innovation? 08/29/11 National
Case Closed on Mirina vs. Marina, as Accelerator Startup Changes Name 06/22/11 Seattle
Will Biotech Ever Again Captivate the Public Imagination, Like Facebook or LinkedIn? 05/16/11 National
Regulus Names Chief Scientist 04/18/11 San Diego
Regulus, UCSD Form Alliance 04/14/11 San Diego
Ligand CEO Outlines Strategy, Arena Rebalances its Debt, Venture Biotech Versus Pharma Debate Flares Anew, & More San Diego Life Sciences News 03/31/11 San Diego
Regulus Gets License From NYU 03/30/11 San Diego
AVI Biopharma Adds Chief Scientist 03/28/11 Seattle
Q&A: UCSF’s Jeff Bluestone on the Tricky Balancing Act Between Academia and Industry 03/10/11 San Francisco
PhaseRx Angles for a Deal, Tom Clement’s New Device Gig(s), InDi’s Alzheimer’s Plan, & More in the Life Science Innovation Northwest Wrap-Up 03/04/11 Seattle
Regulus, the MicroRNA Child of Alnylam and Isis, Offers Litmus Test for Biotech Hope in 2011 02/07/11 San Diego
Some Prognostications on Biotechnology in 2011 01/07/11 San Diego
Santaris Gets $14M From Pfizer 01/04/11 San Diego
Lee Hartwell, at 70, Tackles Personalized Medicine, Education in Latest Career Phase 09/20/10 Seattle
Mirina Vs. Marina: The Looming Court Battle Over Biotech Company Names 08/16/10 Seattle
Accelerator, Taking a Break from Curing Cancer, Unwinds With Some Mini-Golf Hijinks 07/12/10 Seattle
Febit Cuts 60 Percent of Staff 06/23/10 Boston
Regulus Therapeutics, Spinoff of Isis and Alnylam, Forms $750M MicroRNA Deal With Sanofi 06/22/10 San Diego
Page 1 of 2 next page »